Maravai LifeSciences
MRVI
MRVI
159 hedge funds and large institutions have $421M invested in Maravai LifeSciences in 2025 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 46 increasing their positions, 56 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
1% less funds holding
Funds holding: 160 → 159 (-1)
1.13% less ownership
Funds ownership: 90.36% → 89.23% (-1.1%)
18% less repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 56
Holders
159
Holding in Top 10
5
Calls
$3.44M
Puts
$83K
Top Buyers
| 1 | +$9.48M | |
| 2 | +$7.95M | |
| 3 | +$4.88M | |
| 4 |
Millennium Management
New York
|
+$4.57M |
| 5 |
First Eagle Investment Management
New York
|
+$4.54M |
Top Sellers
| 1 | -$12.1M | |
| 2 | -$5.59M | |
| 3 | -$5.52M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$5.36M |
| 5 |
CP
CenterBook Partners
Greenwich,
Connecticut
|
-$4.86M |
